{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:37:05Z","timestamp":1794620225266,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22205201"],"award-info":[{"award-number":["22205201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ23H180003"],"award-info":[{"award-number":["LZ23H180003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","award":["Startup Package"],"award-info":[{"award-number":["Startup Package"]}],"id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fully targeted mRNA therapeutics necessitate simultaneous organ-specific accumulation and effective translation. Despite some progress, delivery systems are still unable to fully achieve this. Here, we reformulate lipid nanoparticles (LNPs) through adjustments in lipid material structures and compositions to systematically achieve the pulmonary and hepatic (respectively) targeted mRNA distribution and expression. A combinatorial library of degradable-core based ionizable cationic lipids is designed, following by optimisation of LNP compositions. Contrary to current LNP paradigms, our findings demonstrate that cholesterol and phospholipid are dispensable for LNP functionality. Specifically, cholesterol-removal addresses the persistent challenge of preventing nanoparticle accumulation in hepatic tissues. By modulating and simplifying intrinsic LNP components, concurrent mRNA accumulation and translation is achieved in the lung and liver, respectively. This targeting strategy is applicable to existing LNP systems with potential to expand the progress of precise mRNA therapy for diverse diseases.<\/jats:p>","DOI":"10.1038\/s41467-024-50093-7","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T10:53:10Z","timestamp":1720176790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":297,"title":["Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0582-9355","authenticated-orcid":false,"given":"Kexin","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0727-1834","authenticated-orcid":false,"given":"Yuxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2571-7721","authenticated-orcid":false,"given":"Yuan","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-4456","authenticated-orcid":false,"given":"Zhen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8405-6743","authenticated-orcid":false,"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"50093_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282\u2013300 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"50093_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436\u2013443 (2023).","journal-title":"Science"},{"key":"50093_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. & Anderson, D. G. The clinical progress of mRNA vaccines and immunotherapies. Nat. Biotechnol. 40, 840\u2013854 (2022).","journal-title":"Nat. Biotechnol."},{"key":"50093_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acs.accounts.1c00739","volume":"55","author":"Y Dong","year":"2022","unstructured":"Dong, Y. & Anderson, D. G. Opportunities and challenges in mRNA therapeutics. Acc. Chem. Res. 55, 1\u20131 (2022).","journal-title":"Acc. Chem. Res."},{"key":"50093_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"50093_CR6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl. Acad. Sci. USA 118, e2109256118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"50093_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","volume":"20","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Mater. 20, 701\u2013710 (2021).","journal-title":"Nat. Mater."},{"key":"50093_CR8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116271119","volume":"119","author":"M Qiu","year":"2022","unstructured":"Qiu, M. et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc. Natl. Acad. Sci. USA 119, e2116271119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"50093_CR9","doi-asserted-by":"publisher","first-page":"eabf4398","DOI":"10.1126\/sciadv.abf4398","volume":"7","author":"M Kim","year":"2021","unstructured":"Kim, M. et al. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Sci. Adv. 7, eabf4398 (2021).","journal-title":"Sci. Adv."},{"key":"50093_CR10","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1021\/acs.nanolett.2c04883","volume":"23","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. STING agonist-derived LNP-mRNA vaccine enhances protective immunity against SARS-CoV-2. Nano Lett. 23, 2593\u20132600 (2023).","journal-title":"Nano Lett."},{"key":"50093_CR11","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1021\/jacs.2c10670","volume":"145","author":"G Tilstra","year":"2023","unstructured":"Tilstra, G. et al. Iterative design of ionizable lipids for intramuscular mRNA. Deliv. J. Am. Chem. Soc. 145, 2294\u20132304 (2023).","journal-title":"Deliv. J. Am. Chem. Soc."},{"key":"50093_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"50093_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat. Protoc. 18, 265\u2013291 (2023).","journal-title":"Nat. Protoc."},{"key":"50093_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","volume":"19","author":"AY Jiang","year":"2024","unstructured":"Jiang, A. Y. et al. Combinatorial development of nebulized mRNA delivery formulations for the lungs. Nat. Nanotechnol. 19, 364\u2013375 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"50093_CR15","doi-asserted-by":"publisher","first-page":"1805116","DOI":"10.1002\/adma.201805116","volume":"31","author":"AK Patel","year":"2019","unstructured":"Patel, A. K. et al. Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium. Adv. Mater. 31, 1805116 (2019).","journal-title":"Adv. Mater."},{"key":"50093_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2020401118","volume":"118","author":"M Qiu","year":"2021","unstructured":"Qiu, M. et al. Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3. Proc. Natl. Acad. Sci. USA 118, e2020401118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"50093_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han, X. et al. An ionizable lipid toolbox for RNA delivery. Nat. Commun. 12, 7233 (2021).","journal-title":"Nat. Commun."},{"key":"50093_CR18","doi-asserted-by":"publisher","first-page":"2303370","DOI":"10.1002\/adma.202303370","volume":"35","author":"MHY Cheng","year":"2023","unstructured":"Cheng, M. H. Y. et al. Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. Adv. Mater. 35, 2303370 (2023).","journal-title":"Adv. Mater."},{"key":"50093_CR19","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41565-023-01455-7","volume":"18","author":"H Tang","year":"2023","unstructured":"Tang, H. et al. Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona. Nat. Nanotechnol. 18, 1067\u20131077 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"50093_CR20","doi-asserted-by":"publisher","first-page":"8341","DOI":"10.1021\/acsnano.8b03640","volume":"12","author":"K Paunovska","year":"2018","unstructured":"Paunovska, K. et al. Analyzing 2000 in vivo drug delivery data points reveals cholesterol structure impacts nanoparticle delivery. ACS Nano 12, 8341\u20138349 (2018).","journal-title":"ACS Nano"},{"key":"50093_CR21","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","volume":"121","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Sun, C., Wang, C., Jankovic, K. E. & Dong, Y. Lipids and lipid derivatives for RNA delivery. Chem. Rev. 121, 12181\u201312277 (2021).","journal-title":"Chem. Rev."},{"key":"50093_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","volume":"20","author":"E Kon","year":"2023","unstructured":"Kon, E., Ad-El, N., Hazan-Halevy, I., Stotsky-Oterin, L. & Peer, D. Targeting cancer with mRNA\u2013lipid nanoparticles: key considerations and future prospects. Nat. Rev. Clin. Oncol. 20, 739\u2013754 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"50093_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41565-019-0600-1","volume":"15","author":"X Hou","year":"2020","unstructured":"Hou, X. et al. Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis. Nat. Nanotechnol. 15, 41\u201346 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"50093_CR24","doi-asserted-by":"publisher","first-page":"e202310395","DOI":"10.1002\/anie.202310395","volume":"62","author":"E \u00c1lvarez-Benedicto","year":"2023","unstructured":"\u00c1lvarez-Benedicto, E. et al. Spleen SORT LNP generated in situ CAR T cells extend survival in a mouse model of lymphoreplete B cell lymphoma. Angew. Chem. Int. Ed. 62, e202310395 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"50093_CR25","doi-asserted-by":"publisher","first-page":"24302","DOI":"10.1021\/jacs.3c09143","volume":"145","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. Modular design of biodegradable ionizable lipids for improved mRNA delivery and precise cancer metastasis delineation in vivo. J. Am. Chem. Soc. 145, 24302\u201324314 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"50093_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"Y Eygeris","year":"2022","unstructured":"Eygeris, Y., Gupta, M., Kim, J. & Sahay, G. Chemistry of lipid nanoparticles for RNA delivery. Acc. Chem. Res. 55, 2\u201312 (2022).","journal-title":"Acc. Chem. Res."},{"key":"50093_CR27","doi-asserted-by":"publisher","first-page":"1606944","DOI":"10.1002\/adma.201606944","volume":"29","author":"OS Fenton","year":"2017","unstructured":"Fenton, O. S. et al. Synthesis and biological evaluation of ionizable lipid materials for the in vivo delivery of messenger RNA to B lymphocytes. Adv. Mater. 29, 1606944 (2017).","journal-title":"Adv. Mater."},{"key":"50093_CR28","doi-asserted-by":"publisher","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"C Hald Albertsen","year":"2022","unstructured":"Hald Albertsen, C. et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv. Drug Deliv. Rev. 188, 114416 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"50093_CR29","doi-asserted-by":"publisher","first-page":"2301929","DOI":"10.1002\/advs.202301929","volume":"10","author":"GS Naidu","year":"2023","unstructured":"Naidu, G. S. et al. A combinatorial library of lipid nanoparticles for cell type-specific mRNA delivery. Adv. Sci. 10, 2301929 (2023).","journal-title":"Adv. Sci."},{"key":"50093_CR30","doi-asserted-by":"publisher","first-page":"2209624","DOI":"10.1002\/adma.202209624","volume":"35","author":"K Lam","year":"2023","unstructured":"Lam, K. et al. Unsaturated, trialkyl ionizable lipids are versatile lipid-nanoparticle components for therapeutic and vaccine applications. Adv. Mater. 35, 2209624 (2023).","journal-title":"Adv. Mater."},{"key":"50093_CR31","doi-asserted-by":"publisher","first-page":"e202405444","DOI":"10.1002\/anie.202405444","volume":"63","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. One\u2010component cationic lipids for systemic mRNA delivery to splenic T cells. Angew. Chem. Int. Ed. 63, e202405444 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"50093_CR32","doi-asserted-by":"publisher","first-page":"21321","DOI":"10.1021\/jacs.1c09822","volume":"143","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Zwitterionic phospholipidation of cationic polymers facilitates systemic mRNA delivery to spleen and lymph nodes. J. Am. Chem. Soc. 143, 21321\u201321330 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"50093_CR33","doi-asserted-by":"publisher","first-page":"18760","DOI":"10.1021\/jacs.3c07337","volume":"145","author":"J Lu","year":"2023","unstructured":"Lu, J. et al. Targeted and equally distributed delivery of mRNA to organs with pentaerythritol-based one-component ionizable amphiphilic Janus dendrimers. J. Am. Chem. Soc. 145, 18760\u201318766 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"50093_CR34","doi-asserted-by":"publisher","first-page":"e2311276120","DOI":"10.1073\/pnas.2311276120","volume":"120","author":"C Wang","year":"2023","unstructured":"Wang, C., Zhao, C., Wang, W., Liu, X. & Deng, H. Biomimetic noncationic lipid nanoparticles for mRNA delivery. Proc. Natl. Acad. Sci. USA 120, e2311276120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"50093_CR35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41557-023-01138-9","volume":"15","author":"MZC Hatit","year":"2023","unstructured":"Hatit, M. Z. C. et al. Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery. Nat. Chem. 15, 508\u2013515 (2023).","journal-title":"Nat. Chem."},{"key":"50093_CR36","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jconrel.2023.12.017","volume":"365","author":"S He","year":"2024","unstructured":"He, S. & Liu, S. Zwitterionic materials for nucleic acid delivery and therapeutic applications. J. Controlled Release 365, 919\u2013935 (2024).","journal-title":"J. Controlled Release"},{"key":"50093_CR37","doi-asserted-by":"publisher","first-page":"e2301067120","DOI":"10.1073\/pnas.2301067120","volume":"120","author":"L Zheng","year":"2023","unstructured":"Zheng, L., Bandara, S. R., Tan, Z. & Leal, C. Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm. Proc. Natl. Acad. Sci. USA 120, e2301067120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"50093_CR38","doi-asserted-by":"publisher","first-page":"E3351","DOI":"10.1073\/pnas.1720542115","volume":"115","author":"M Yanez Arteta","year":"2018","unstructured":"Yanez Arteta, M. et al. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proc. Natl.Acad. Sci. USA 115, E3351\u2013E3360 (2018).","journal-title":"Proc. Natl.Acad. Sci. USA"},{"key":"50093_CR39","doi-asserted-by":"publisher","first-page":"2303614","DOI":"10.1002\/adma.202303614","volume":"35","author":"R Zhang","year":"2023","unstructured":"Zhang, R. et al. Esterase-labile quaternium lipidoid enabling improved mRNA-LNP stability and spleen-selective mRNA transfection. Adv. Mater. 35, 2303614 (2023).","journal-title":"Adv. Mater."},{"key":"50093_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12275-6","volume":"10","author":"M Maugeri","year":"2019","unstructured":"Maugeri, M. et al. Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells. Nat. Commun. 10, 4333 (2019).","journal-title":"Nat. Commun."},{"key":"50093_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201805097","volume":"15","author":"KA Hajj","year":"2019","unstructured":"Hajj, K. A. et al. Branched-tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH. Small 15, 1805097 (2019).","journal-title":"Small"},{"key":"50093_CR42","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.7150\/thno.87316","volume":"13","author":"L Lin","year":"2023","unstructured":"Lin, L., Su, K., Cheng, Q. & Liu, S. Targeting materials and strategies for RNA delivery. Theranostics 13, 4667\u20134693 (2023).","journal-title":"Theranostics"},{"key":"50093_CR43","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41565-020-0759-5","volume":"15","author":"W Poon","year":"2020","unstructured":"Poon, W., Kingston, B. R., Ouyang, B., Ngo, W. & Chan, W. C. W. A framework for designing delivery systems. Nat. Nanotechnol. 15, 819\u2013829 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"50093_CR44","doi-asserted-by":"publisher","first-page":"2303795","DOI":"10.1002\/adfm.202303795","volume":"33","author":"MM Abd Elwakil","year":"2023","unstructured":"Abd Elwakil, M. M. et al. Harnessing topology and stereochemistry of glycidylamine-derived lipid nanoparticles for in vivo mRNA delivery to immune cells in spleen and their application for cancer vaccination. Adv. Funct. Mater. 33, 2303795 (2023).","journal-title":"Adv. Funct. Mater."},{"key":"50093_CR45","doi-asserted-by":"publisher","first-page":"eade1444","DOI":"10.1126\/sciadv.ade1444","volume":"9","author":"JR Melamed","year":"2023","unstructured":"Melamed, J. R. et al. Ionizable lipid nanoparticles deliver mRNA to pancreatic \u03b2 cells via macrophage-mediated gene transfer. Sci. Adv. 9, eade1444 (2023).","journal-title":"Sci. Adv."},{"key":"50093_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35637-z","volume":"14","author":"X Han","year":"2023","unstructured":"Han, X. et al. Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis. Nat. Commun. 14, 75 (2023).","journal-title":"Nat. Commun."},{"key":"50093_CR47","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","volume":"41","author":"B Li","year":"2023","unstructured":"Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410\u20131415 (2023).","journal-title":"Nat. Biotechnol."},{"key":"50093_CR48","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","volume":"345","author":"ST LoPresti","year":"2022","unstructured":"LoPresti, S. T., Arral, M. L., Chaudhary, N. & Whitehead, K. A. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs. J. Controlled Release 345, 819\u2013831 (2022).","journal-title":"J. Controlled Release"},{"key":"50093_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42948-2","volume":"14","author":"T Wei","year":"2023","unstructured":"Wei, T. et al. Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models. Nat. Commun. 14, 7322 (2023).","journal-title":"Nat. Commun."},{"key":"50093_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39768-9","volume":"14","author":"K Liu","year":"2023","unstructured":"Liu, K. et al. Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function. Nat. Commun. 14, 4007 (2023).","journal-title":"Nat. Commun."},{"key":"50093_CR51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307801120","volume":"121","author":"A Radmand","year":"2024","unstructured":"Radmand, A. et al. Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart. Proc. Natl. Acad. Sci. USA 121, e2307801120 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"50093_CR52","doi-asserted-by":"publisher","first-page":"2300188","DOI":"10.1002\/advs.202300188","volume":"10","author":"S Du","year":"2023","unstructured":"Du, S. et al. Cholesterol\u2010Amino\u2010Phosphate (CAP) derived lipid nanoparticles for delivery of self\u2010amplifying RNA and restoration of spermatogenesis in infertile mice. Adv. Sci. 10, 2300188 (2023).","journal-title":"Adv. Sci."},{"key":"50093_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14527-2","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel, S. et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat. Commun. 11, 983 (2020).","journal-title":"Nat. Commun."},{"key":"50093_CR54","doi-asserted-by":"publisher","first-page":"1807748","DOI":"10.1002\/adma.201807748","volume":"31","author":"K Paunovska","year":"2019","unstructured":"Paunovska, K. et al. Nanoparticles containing oxidized cholesterol deliver mRNA to the liver microenvironment at clinically relevant doses. Adv. Mater. 31, 1807748 (2019).","journal-title":"Adv. Mater."},{"key":"50093_CR55","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1039\/D1CS00617G","volume":"51","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y. et al. Emerging mRNA technologies: delivery strategies and biomedical applications. Chem. Soc. Rev. 51, 3828\u20133845 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"50093_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39938-9","volume":"14","author":"F Li","year":"2023","unstructured":"Li, F. et al. mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy. Nat. Commun. 14, 4223 (2023).","journal-title":"Nat. Commun."},{"key":"50093_CR57","doi-asserted-by":"publisher","unstructured":"Bourgognon, M., Klippstein, R. & Al-Jamal, K. T. Kupffer cell isolation for nanoparticle toxicity testing. J. Vis. Exp. 52989 https:\/\/doi.org\/10.3791\/52989 (2015).","DOI":"10.3791\/52989"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50093-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50093-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50093-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T11:03:37Z","timestamp":1720177417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50093-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50093"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50093-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.S. and S.L. have filed the patent application on this research. Y.P. is a scientific co-founder of Ruidax. Z.G. is the co-founder of Zenomics Inc., Zcapsule Inc. and \u03bcZen Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5659"}}